SBU Researchers Developing Drug to Cut Down Growth of Cancer Cells
April 11, 2014
New research has found that it is possible to cut down the growth of cancer cells at their earliest stages with a new drug.
Research conducted by leading cancer metabolism researchers at Stony Brook University, Paul M. Bingham and Zuzana Zachar, is showing promise in this approach with their clinical investigation of a new class of compounds that disrupt cancer cell mitochondrial metabolism. In collaboration with Cornerstone Pharmaceuticals, Drs. Bingham, Zachar and colleagues at Stony Brook University are evaluating the basic mechanisms of actions behind this class of agents. The relationship with Cornerstone has its roots within Stony Brook’s Center for Biotechnology. Read more here.